Cannell Capital’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
Other funds holding ETON
OM
Cannell Capital's ETON Position: Q3 2026 in Review
Cannell Capital reduced its Eton Pharmaceutcials (ETON) stake by 59% in Q3 2026, selling an estimated $5.08M and leaving 70,607 shares worth $3.64M. The position accounts for 3.21% of the portfolio, ranked #15.
Cannell Capital first reported a position in ETON in Q4 2024 and has held it in 8 quarters since. The position peaked at $9.9M in Q3 2025. 214 funds tracked by Wall St. Rank hold ETON as of Q3 2026.
- Cannell Capital held 70,607 shares of Eton Pharmaceutcials worth $3.64M as of Q3 2026.
- Cannell Capital sold 100,140 Eton Pharmaceutcials shares in Q3 2026, an estimated $5.08M.
- Eton Pharmaceutcials made up 3.21% of Cannell Capital's portfolio in Q3 2026, its #15 holding.
- Cannell Capital first reported a position in Eton Pharmaceutcials in Q4 2024 and has held it in 8 quarters since.
- Cannell Capital's Eton Pharmaceutcials position peaked at $9.9M in Q3 2025.
- 214 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.
Based on Cannell Capital's 13F filing for Q3 2026, filed 16 Nov 2026.